Literature DB >> 18946456

Comparison between CRP and IL-6 as early markers of neonatal sepsis.

M K Noor1, M Shahidullah, M Mutanabbi, C Barua, M A Mannan, S Afroza.   

Abstract

Infection in neonates is difficult to identify solely on the basis of physical findings, because signs are not specific. C reactive protein (CRP) is an acute phase reactant which has been used in diagnosis of bacterial infection in neonates. IL-6 is a proinflammatory cytokine produced by monocytes and macrophages activated by bacterial infection. IL-6 can be detected in blood earlier than CRP during the course of bacterial infection. The objective of this study was to compare the usefulness of the level of interleukin-6 with CRP as early markers of neonatal sepsis. This was a queasy experimental study carried out in neonatal unit, Department of Pediatrics, Bangabandhu Sheikh Mujib Medical University (BSMMU) during the period of September 2005 to February 2006. Forty five cases of suspected septicemia were enrolled in the study and thirty healthy newborns were taken for comparison. On the 1st day of symptoms and 1st day of admission, complete blood count, blood for culture and sensitivity and interleukin-6 (IL-6) estimation were done. After 48-72 hours CRP was estimated. In suspected septic babies with high leukocyte count, IL-6 level was found to be raised with high sensitivity (85.71%), negative predictive value (95%). IL-6 was found to have high sensitivity (76.9%), specificity (73.68%), positive predictive value (80%) and negative predictive value (70%) in CRP positive suspected sepsis cases. So, the conclusion was that IL-6 is a very early marker of neonatal infection. IL-6 was mostly positive within 24 hours of onset of sepsis in comparison with other tests. So IL-6 is more useful than other markers for early detection of neonatal sepsis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946456

Source DB:  PubMed          Journal:  Mymensingh Med J        ISSN: 1022-4742


  8 in total

1.  Evaluation of potential biomarkers for the discrimination of bacterial and viral infections.

Authors:  P Chalupa; O Beran; H Herwald; N Kaspříková; M Holub
Journal:  Infection       Date:  2011-07-01       Impact factor: 3.553

2.  Evaluation of Procalcitonin, C-Reactive Protein, and Interleukin-6 as Early Markers for Diagnosis of Neonatal Sepsis.

Authors:  Emad A Morad; Rehab A Rabie; Mohamed A Almalky; Manar G Gebriel
Journal:  Int J Microbiol       Date:  2020-10-01

3.  Detection of membrane-bound and soluble antigens by magnetic levitation.

Authors:  Mikkel Schou Andersen; Emily Howard; Shulin Lu; Matthew Richard; Mark Gregory; Gordon Ogembo; Ofer Mazor; Pavel Gorelik; Nathan I Shapiro; Anish V Sharda; Ionita Ghiran
Journal:  Lab Chip       Date:  2017-10-11       Impact factor: 6.799

4.  Combination of 16S rRNA and procalcitonin in diagnosis of neonatal clinically suspected sepsis.

Authors:  Renqiang Yu; Qin Zhou; Shanyu Jiang; Yingzi Mei; Min Wang
Journal:  J Int Med Res       Date:  2019-12-19       Impact factor: 1.671

Review 5.  Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure.

Authors:  Lili Zhang; Jianhua Hu; Chunyan Gou; Hua Jin; Chun Zhang; Yang Liu; Yitong Wang; Xiaojun Wang
Journal:  Mediators Inflamm       Date:  2022-09-08       Impact factor: 4.529

6.  Neonatal infections in Saudi Arabia: association with C-reactive protein, CRP -286 (C>T>A) gene polymorphism and IgG antibodies.

Authors:  Amre Nasr; Gamal Allam; Ali Al-Zahrani; Adnan Alsulaimani
Journal:  BMC Immunol       Date:  2013-08-13       Impact factor: 3.615

7.  Diagnostic value of serum leptin and a promising novel diagnostic model for sepsis.

Authors:  Mingyi Chen; Bin Wang; Yaping Xu; Zihui Deng; Hui Xue; Luhuan Wang; Lei He
Journal:  Exp Ther Med       Date:  2014-01-27       Impact factor: 2.447

8.  High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure.

Authors:  Chao Zhou; Ning Zhang; Ting-Ting He; Yao Wang; Li-Fu Wang; Yong-Qiang Sun; Jing Jing; Jing-Jing Zhang; Shuang-Nan Fu; Xuan Wang; Xiao-Xiao Liang; Xin Li; Man Gong; Jun Li
Journal:  World J Gastroenterol       Date:  2020-08-14       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.